论文信息 - A phase 1 trial extension to assess immunologic efficacy and safety of prime-boost vaccination with VXM01, an oral T cell vaccine against VEGFR2, in patients with advanced pancreatic cancer - 字舞流文

A phase 1 trial extension to assess immunologic efficacy and safety of prime-boost vaccination with VXM01, an oral T cell vaccine against VEGFR2, in patients with advanced pancreatic cancer

M. Büchler | W. Haefeli | K. Breiner | Sébastien Wieckowski | C. Springfeld | G. Mikus | L. Grenacher | P. Beckhove | Mariana Bucur | T. Schmidt | P. Knebel | N. Hohmann | H. Lubenau | F. Schmitz-Winnenthal | M. Springer | R. Koc | A. Keller | L. Podola | T. Friedrich